FDA Inspection 1064104 — Lexicon Pharmaceuticals Inc
The FDA completed an inspection of Lexicon Pharmaceuticals Inc on Jul 13, 2018 in Spring, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Spring, TX (United States)
Additional Details
Sponsor, Contract Research Organization